论文部分内容阅读
目的:观察氯沙坦联合胺碘酮预防阵发性心房颤动的临床效果。方法:选择126例阵发性心房颤动的患者,随机分为氯沙坦联合胺碘酮组和胺碘酮组,每组各63例,治疗12个月,比较观察两组患者心房颤动的发生率。结果:氯沙坦联合胺碘酮组总有效率为87.3%;胺碘酮组总有效率为68.3%,两组比较差异有统计学意义(P<0.05)。结论:氯沙坦联合胺碘酮较单用胺碘酮更好地预防阵发性心房颤动的复发。
Objective: To observe the clinical efficacy of losartan combined with amiodarone in preventing paroxysmal atrial fibrillation. Methods: 126 patients with paroxysmal atrial fibrillation were randomly divided into losartan with amiodarone group and amiodarone group, 63 cases in each group for 12 months. The incidence of atrial fibrillation rate. Results: The total effective rate of losartan plus amiodarone group was 87.3%. The total effective rate of amiodarone group was 68.3%. There was significant difference between the two groups (P <0.05). Conclusion: Losartan combined with amiodarone is better than amiodarone alone in preventing the recurrence of paroxysmal atrial fibrillation.